Alerts will be sent to your verified email
Verify Email
RPGLIFE
|
RPG Life Sciences
|
Dishman Carbogen Amc
|
Advanced Enzyme
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
Domestic Sales Growth - YoY
|
-11.18 % | n/a | n/a |
|
R&D as a % of Total Sales
|
1.11 % | 1.64 % | 10.41 % |
|
Financials
|
|||
|
5 yr Average ROE
|
23.71 % | -1.15 % | 10.77 % |
|
5yr average Equity Multiplier
|
1.34 | 1.61 | 1.15 |
|
5yr Average Asset Turnover Ratio
|
1.18 | 0.26 | 0.41 |
|
5yr Avg Net Profit Margin
|
15.65 % | -2.96 % | 22.63 % |
|
Price to Book
|
5.92 | 0.51 | 2.25 |
|
P/E
|
16.18 | 23.67 | 22.66 |
|
5yr Avg Cash Conversion Cycle
|
-53.67 Days | 24.66 Days | 109.31 Days |
|
Inventory Days
|
61.98 Days | 110.18 Days | 77.49 Days |
|
Days Receivable
|
35.4 Days | 77.38 Days | 61.31 Days |
|
Days Payable
|
143.49 Days | 156.95 Days | 49.86 Days |
|
5yr Average Interest Coverage Ratio
|
30.59 | 0.4 | 54.21 |
|
5yr Avg ROCE
|
28.37 % | 0.91 % | 14.52 % |
|
5yr Avg Operating Profit Margin
|
20.94 % | 13.93 % | 35.47 % |
|
5 yr average Debt to Equity
|
0.0 | 0.3 | 0.02 |
|
5yr CAGR Net Profit
|
35.58 % | n/a | -2.12 % |
|
5yr Average Return on Assets
|
17.85 % | -0.73 % | 9.32 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.95 % | 59.32 % | 43.04 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.34 % | 0.0 | -6.83 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.04 % | -2.55 % | -3.09 % |
|
RPG Life Sciences
|
Dishman Carbogen Amc
|
Advanced Enzyme
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|